
M.E/CFS effects millions of people world wide.
Its physical symptoms can be as disabling as multiple sclerosis, congestive heart failure and other chronic conditions, yet little is known about the cause due to lack of biomedical research.
What is M.E/CFS?
ME (Myalgic Encephalomyelitis) is a severely debilitating neurological illness estimated to affect between 150,000 and 250,000 people in the U.K, and millions globally. It may be diagnosed as Chronic Fatigue Syndrome (CFS) or Post Viral Fatigue Syndrome (PVFS).
The World Health Organisation defines ME as a neurological illness. It is characterised by a range of neurological or cognitive symptoms including severe and long-lasting payback and slow recovery times associated with even minor activities (post-exertional fatigue) which can affect cognitive processes as much as physical ones. Patients are also prone to relapses which may take the form of the original systemic illness, or fresh episodes of muscular or other symptoms.
M.E worldwide
Estimates and definitions vary greatly, and there are few studies done on the prevalence of M.E/CFS, but estimated figures for some countries are up to:
- America 1 – 2.4 million
- Australia 180,000
- Canada 530,000
- Europe 1 million
- Japan 300,000
- UK 250,000
What is the cause?
Very little research has been done and the cause of ME/CFS is still unknown, but there is unlikely to be a single causative agent. Several past epidemics appear to have been triggered by an outbreak of an infection which then subsided, and still today many patients report a variety of contributing factors (including infectious, traumatic, environmental) all of which can lead to a condition which shares a common set of symptoms.
ME/CFS is a relatively common illness. Its physical symptoms can be as disabling as multiple sclerosis, congestive heart failure and other chronic conditions, and it places a substantial burden on patients, families and carers, and on society.
Living with M.E
It is estimated that between 150,000 and 250,000 people in the UK have ME/CFS, a prevalence higher than HIV infection or multiple sclerosis. It is twice as commonly reported in women as men. Studies indicate that most people with ME/CFS are unable to work to full capacity and that a significant number (from 10 to 25%) are effectively house or bed-bound. It is now known that ME/CFS affects all social groups and all ages, including children. Sadly there have been many people this year who have lost their lives due to M.E, the resulting complications, or inadequate care.
The 2021 UK NICE guidelines give a current overview of clinical best practice for managing M.E/CFS.
Symptoms
Symptoms can range from mild to severe to life-threatening and can include:
- Cardiac and cardiovascular problems
- Cognitive dysfunction
- Gastro-intestinal problems
- Headaches
- Hormonal imbalance
- Immunological problems
- Muscle weakness and intense pain
- Neurological problems
- Sleep problems
You can find out more about current research, living with ME/CFS, and useful links here.
